Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Klebsiella oxytoca

Identifiers: BioSample: SAMN41091866; Sample name: BWH_1911_K_oxy; SRA: SRS21133319

Organism: Klebsiella oxytoca
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_1911_K_oxy
collected by	Brigham and Women's Hospital
collection date	2024
geographic location	USA:Boston
host	Homo sapiens
host disease	Genital infection
isolation source	Labia
latitude and longitude	42.3362 N 71.1067 W
host age	70

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2024-04-26

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
ceftriaxone	resistant	==	8	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	susceptible	<=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
doxycycline	susceptible	==	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
linezolid	intermediate	==	4	mg/L	MIC		Biomérieux	E-Test	CLSI
amoxicillin-clavulanic acid	resistant	>=	32/16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
daptomycin	susceptible	==	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	19/1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	resistant	>=	128/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
vancomycin	susceptible	==	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
erythromycin	susceptible	==	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ertapenem	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN41091866
ID:: 41091866

BioProject SRA Nucleotide

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

Pathogen: clinical or host-associated sample from Klebsiella oxytoca

Supplemental Content

Related information

Recent activity